查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888612

全球标靶DNA和RNA定序市场：市场规模、份额和趋势分析（按工作流程、技术、应用、类型、最终用途和地区划分），细分市场预测（2025-2033年）

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Technology, By Application, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

标靶DNA和RNA定序市场概览

全球标靶DNA和RNA定序市场预计在2024年达到74亿美元，预计2033年将达到345.6亿美元。

预计从 2025 年到 2033 年，该市场将以 18.98% 的复合年增长率成长。由于精准医疗的日益普及、癌症和遗传疾病发病率的上升，以及对更具成本效益和高度精确的测序方法的需求（这些方法能够对特定基因和基因组区域进行深入分析），该市场正在快速增长。

对精准诊断和标靶治疗的需求日益增长

癌症、心臟病和遗传性疾病等疾病发生率的上升，推动了对疾病诊断和特异性治疗方法的需求，进而促进了市场成长。标靶定序能够更早识别致病突变，从而有助于诊断并改善治疗方案。这对于可采用标靶治疗治疗的癌症类型尤其重要，因为标靶疗法的副作用可能比化疗少。

此外，标靶定序正在推动向个人化、微创治疗的转型，尤其是在肿瘤学和罕见疾病领域。识别可操作的基因改变使临床医生能够选择比标准化疗或广谱治疗更有效、毒性更小的标靶治疗。实现个人化医疗、最大限度降低毒性并改善患者预后的能力，持续推动着标靶定序在临床、研究和製药领域的应用，并成为医学创新和市场扩张的重要推动力。

技术进步和成本效益的提高将加速其普及应用。

新一代定序平台、富集化学和自动化技术的进步，使得标靶定序速度更快、更准确、成本显着降低。改良的捕获试剂盒、高通量系统和高性能试剂等创新技术，缩短了处理时间和周转时间，从而支持了医院、研究实验室和生物技术公司等机构的应用。

此外，标靶定序仅针对特定基因区域，能够提供更深的覆盖度和更高的灵敏度，从而检测出罕见变异，其性能优于全基因组定序。由于数据分析要求更低、储存需求更少、工作流程更经济高效，靶向测序正日益被医疗机构应用于常规诊断、精准医疗和大规模基因组学计画等领域。这种基于效率的价值提案持续推动市场扩张。

目录

第一章 分析方法和范围

第二章执行摘要

3. 标靶DNA和RNA定序市场：驱动因素、趋势和范围

  • 市场概览/关係展望
  • 市场规模和成长率预测
  • 市场动态
  • 商业环境分析
    • PESTLE分析
    • 波特五力分析

第四章：靶向DNA和RNA测序市场：按技术分類的估算和趋势分析

  • 标靶DNA和RNA定序市场：按技术分類的变异分析（2023年和2033年）
  • 下一代定序（NGS）
  • 其他的

第五章 标靶DNA和RNA定序市场：依工作流程分類的估算与趋势分析

  • 按变异分析和工作流程分類的标靶DNA和RNA定序市场（2023年和2033年）
  • 前序
  • 顺序
  • 数据分析

第六章：靶向DNA和RNA测序市场：按应用分類的估计和趋势分析

  • 标靶DNA和RNA定序市场：按应用领域分類的变化分析（2023年和2033年）
  • 人类生物医学研究
  • 植物和动物科学
  • 药物发现
  • 其他的

第七章：标靶DNA和RNA定序市场：按类型分類的估计和趋势分析

  • 标靶DNA和RNA定序市场：按类型分類的变化分析（2023年和2033年）
  • 基于DNA的标靶定序
  • 基于RNA的标靶定序

8. 标靶DNA和RNA定序市场：依最终用途分類的估算与趋势分析

  • 按变异分析和最终用途分類的标靶DNA和RNA定序市场（2023年和2033年）
  • 学术与研究
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

9. 标靶DNA和RNA定序市场：区域估算与趋势分析

  • 标靶DNA和RNA定序市场：按地区分類的市场份额（百万美元，2024年和2033年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲标靶DNA和RNA定序市场（2021-2033年）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区标靶DNA和RNA定序市场（2021-2033年）
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲标靶DNA和RNA定序市场（2021-2033年）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲标靶DNA和RNA定序市场（2021-2033年）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司分类
  • 策略规划
  • 企业市场分析（2024）
  • 公司简介/列表
    • Illumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
Product Code: GVR-1-68038-681-3

Targeted DNA RNA Sequencing Market Summary

The global targeted DNA RNA sequencing market size was estimated at USD 7.40 billion in 2024 and is projected to reach USD 34.56 billion by 2033, expanding at a CAGR of 18.98% from 2025 to 2033. The market is growing rapidly due to the increasing use of precision medicine, the rising incidence of cancer and genetic diseases, and the demand for more cost-efficient and highly accurate sequencing methodologies that enable the deep analysis of specific genes or genomic regions.

Growing Demand for Precision Diagnostics and Targeted Therapies

With the rising incidences of diseases such as cancer, heart diseases, and genetic disorders, the need to diagnose and develop specific treatments drives the market growth. In targeted sequencing, it is possible to identify pathogenic variations at an earlier stage in the process, which facilitates diagnosis and improves treatment options. This is particularly sensitive if the cancer type can be treated with targeted therapy that may not cause as many side effects as chemotherapy.

Moreover, targeted sequencing facilitates the transition to personalized, less invasive therapies, particularly in the fields of oncology and rare disease. By identifying actionable genetic mutations, clinicians can select targeted therapies that are both more effective and have lower toxicity compared to standard chemotherapy or broad-spectrum treatments. The capacity for individualized care, minimal toxicity, and improved patient outcomes continues to drive the use of targeted sequencing in the clinical, research, and pharmaceutical sectors, making it a major contributor to healthcare innovation and market expansion.

Technological Advancements and Cost Efficiency Accelerating Adoption

Advances in next-generation sequencing platforms, enrichment chemistry, and automation make targeted sequencing faster, more accurate, and significantly less costly. Innovations such as improved capture kits, high-throughput systems, and enhanced reagents are reducing processing and turnaround times, thereby supporting applications in hospitals, research laboratories, and biotech companies.

Moreover, targeted sequencing focuses on only selected gene regions, allowing for deeper coverage and increased sensitivity in detecting rarer variants, which is superior to whole-genome sequencing. Given that targeted sequencing has lower data analysis requirements, fewer storage needs, and cost-efficient workflows, it is increasingly chosen by healthcare providers in areas such as routine diagnostics, precision medicine, and large genomic programs. This value proposition, based on efficiencies, continues to drive market expansion.

Global Targeted DNA RNA Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global targeted DNA RNA sequencing market based on technology, workflow, application, type, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • NGS
    • Method
    • Exome Sequencing
    • Enrichment Sequencing
    • Amplicon Sequencing
    • Others
    • Application
    • Cancer Gene Sequencing
    • Inherited Disease Screening
    • Drug Development
    • Forensic Genomics
    • 16S ribosomal RNA (rRNA) sequencing
  • Others
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-sequencing
  • Sequencing
  • Data Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Biomedical Research
  • Plant & Animal Sciences
  • Drug Discovery
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Based Targeted Sequencing
  • RNA Based Targeted Sequencing
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology
    • 1.2.2. Workflow
    • 1.2.3. Application
    • 1.2.4. Type
    • 1.2.5. End Use
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Growing Demand for Precision Diagnostics and Targeted Therapies
      • 3.3.1.2. Technological Advancements and Cost Efficiency Accelerating Adoption
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High Initial Capital Investment
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, USD Million, 2023 & 2033
  • 4.3. NGS
    • 4.3.1. NGS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Method Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.1. Exome Sequencing
        • 4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Enrichment Sequencing
        • 4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Amplicon Sequencing
        • 4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Application Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.1. Cancer Gene Sequencing
        • 4.3.3.1.1. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Inherited Disease Screening
        • 4.3.3.2.1. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Drug Development
        • 4.3.3.3.1. Drug Development Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Forensic Genomics
        • 4.3.3.4.1. Forensic Genomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.5. 16S Ribosomal RNA (rRNA)
        • 4.3.3.5.1. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, USD Million, 2023 & 2033
  • 5.3. Pre-sequencing
    • 5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Sequencing
    • 5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Data Analysis
    • 5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, USD Million, 2023 & 2033
  • 6.3. Human Biomedical Research
    • 6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Plant & Animal Sciences
    • 6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery
    • 6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, USD Million, 2023 & 2033
  • 7.3. DNA Based Targeted Sequencing
    • 7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. RNA Based Targeted Sequencing
    • 7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, USD Million, 2023 & 2033
  • 8.3. Academic Research
    • 8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Pharma & Biotech Entities
    • 8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2024 & 2033, USD Million
  • 9.2. North America
    • 9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. U.S. targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Canada targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Competitive Scenario
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Mexico targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. UK targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Germany targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. France targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Italy targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Spain targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Denmark targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Sweden targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Norway targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Japan targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. China targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. India targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Australia targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Thailand targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. South Korea targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Brazil targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Argentina targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. South Africa targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Saudi Arabia targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. UAE targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Kuwait targeted DNA RNA sequencing market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Illumina
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. F. Hoffman-La Roche Ltd.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. QIAGEN
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Bio-Rad Laboratories, Inc.
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Oxford Nanopore Technologies
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. PierianDx
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Genomatix GmbH
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. DNASTAR, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Perkin Elmer, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4. Global Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 5. Global Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. Global Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 7. Global Targeted DNA RNA Sequencing Market, End Use, 2021 - 2033 (USD Million)
  • Table 8. Global Targeted DNA RNA Sequencing Market, by Region, 2021 - 2033 (USD Million)
  • Table 9. North America Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 10. North America Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 11. North America Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 12. North America Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 13. North America Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 14. North America Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 15. U.S. Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16. U.S. Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 17. U.S. Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 18. U.S. Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 19. U.S. Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Canada Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 21. Canada Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 22. Canada Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 23. Canada Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 24. Canada Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25. Mexico Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 26. Mexico Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 27. Mexico Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 28. Mexico Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 29. Mexico Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30. Europe Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 31. Europe Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 32. Europe Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 33. Europe Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 34. Europe Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 35. Europe Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36. Germany Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37. Germany Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 38. Germany Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 39. Germany Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 40. Germany Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41. UK Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 42. UK Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 43. UK Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 44. UK Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 45. UK Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46. France Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 47. France Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 48. France Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 49. France Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 50. France Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51. Italy Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 52. Italy Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 53. Italy Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 54. Italy Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 55. Italy Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 56. Spain Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57. Spain Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 58. Spain Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 59. Spain Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 60. Spain Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Denmark Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62. Denmark Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 63. Denmark Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 64. Denmark Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 65. Denmark Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66. Norway Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 67. Norway Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 68. Norway Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 69. Norway Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 70. Norway Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71. Sweden Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 72. Sweden Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 73. Sweden Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 74. Sweden Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 75. Sweden Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76. Asia Pacific Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 77. Asia Pacific Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78. Asia Pacific Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 79. Asia Pacific Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 80. Asia Pacific Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 81. Asia Pacific Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82. China Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 83. China Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 84. China Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 85. China Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 86. China Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87. Japan Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88. Japan Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 89. Japan Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 90. Japan Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 91. Japan Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92. India Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 93. India Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 94. India Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 95. India Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 96. India Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97. South Korea Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 98. South Korea Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 99. South Korea Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 100. South Korea Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 101. South Korea Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 102. Australia Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103. Australia Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 104. Australia Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 105. Australia Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 106. Australia Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 107. Thailand Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 108. Thailand Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 109. Thailand Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 110. Thailand Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 111. Thailand Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112. Latin America Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 113. Latin America Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 114. Latin America Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 115. Latin America Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 116. Latin America Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 117. Latin America Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 118. Brazil Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 119. Brazil Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 120. Brazil Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 121. Brazil Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 122. Brazil Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 123. Argentina Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124. Argentina Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 125. Argentina Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 126. Argentina Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 127. Argentina Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128. Middle East and Africa Targeted DNA RNA Sequencing Market, by Country, 2021 - 2033 (USD Million)
  • Table 129. Middle East and Africa Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 130. Middle East and Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 131. Middle East and Africa Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 132. Middle East and Africa Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 133. Middle East and Africa Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 134. South Africa Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 135. South Africa Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 136. South Africa Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 137. South Africa Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 138. South Africa Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 139. Saudi Arabia Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 140. Saudi Arabia Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 141. Saudi Arabia Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 142. Saudi Arabia Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 143. Saudi Arabia Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 144. UAE Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 145. UAE Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 146. UAE Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 147. UAE Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 148. UAE Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 149. Kuwait Targeted DNA RNA Sequencing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 150. Kuwait Targeted DNA RNA Sequencing Market, by Workflow, 2021 - 2033 (USD Million)
  • Table 151. Kuwait Targeted DNA RNA Sequencing Market, by Application, 2021 - 2033 (USD Million)
  • Table 152. Kuwait Targeted DNA RNA Sequencing Market, by Type, 2021 - 2033 (USD Million)
  • Table 153. Kuwait Targeted DNA RNA Sequencing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Targeted DNA RNA sequencing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Targeted DNA RNA sequencing market: Technology outlook key takeaways
  • Fig. 19 Targeted DNA RNA sequencing market: Technology movement analysis
  • Fig. 20 NGS, 2021 - 2033 (USD Million)
  • Fig. 21 Exome sequencing, 2021 - 2033 (USD Million)
  • Fig. 22 Enrichment sequencing, 2021 - 2033 (USD Million)
  • Fig. 23 Amplicon sequencing, 2021 - 2033 (USD Million)
  • Fig. 24 Others, 2021 - 2033 (USD Million)
  • Fig. 25 Cancer gene sequencing, 2021 - 2033 (USD Million)
  • Fig. 26 Inherited disease screening, 2021 - 2033 (USD Million)
  • Fig. 27 Drug development, 2021 - 2033 (USD Million)
  • Fig. 28 Forensic genomics, 2021 - 2033 (USD Million)
  • Fig. 29 16S ribosomal RNA (rRNA) sequencing, 2021 - 2033 (USD Million)
  • Fig. 30 Others, 2021 - 2033 (USD Million)
  • Fig. 31 Targeted DNA RNA sequencing market: Workflow outlook key takeaways
  • Fig. 32 Targeted DNA RNA sequencing market: Workflow movement analysis
  • Fig. 33 Pre-sequencing, 2021 - 2033 (USD Million)
  • Fig. 34 Sequencing, 2021 - 2033 (USD Million)
  • Fig. 35 Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 36 Targeted DNA RNA sequencing market: Application outlook key takeaways
  • Fig. 37 Targeted DNA RNA sequencing market: Application movement analysis
  • Fig. 38 Human Biomedical Research, 2021 - 2033 (USD Million)
  • Fig. 39 Plant & Animal Sciences, 2021 - 2033 (USD Million)
  • Fig. 40 Drug Discovery, 2021 - 2033 (USD Million)
  • Fig. 41 Others, 2021 - 2033 (USD Million)
  • Fig. 42 Targeted DNA RNA sequencing market: Type outlook key takeaways
  • Fig. 43 Targeted DNA RNA sequencing market: Type movement analysis
  • Fig. 44 DNA Based Targeted Sequencing, 2021 - 2033 (USD Million)
  • Fig. 45 RNA Based Targeted Sequencing, 2021 - 2033 (USD Million)
  • Fig. 46 Targeted DNA RNA sequencing market: End use outlook key takeaways
  • Fig. 47 Targeted DNA RNA sequencing market: End use movement analysis
  • Fig. 48 Academic Research, 2021 - 2033 (USD Million)
  • Fig. 49 Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 50 Pharma & Biotech Entities, 2021 - 2033 (USD Million)
  • Fig. 51 Other Users, 2021 - 2033 (USD Million)
  • Fig. 52 Regional marketplace outlook, 2024 & 2033, (USD Million)
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Europe targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Germany targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific targeted DNA RNA sequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 MEA targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait targeted DNA RNA sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Market position analysis
  • Fig. 106 Market participant categorization
  • Fig. 107 Strategic framework